I'm working in...
Arrow for button
Cross Arrow

I'm working in...

Role
Company
Select

How are companies distinguishing between “moonshot” automation and validated digital tools that can be deployed today?

Venu Mallarapu, Chief Transformation and AI Officer, eClinical Solutions

Agentic AI can deliver insights in seconds rather than days, and in an industry where that speed can accelerate lifesaving therapies to patients, the potential is difficult to ignore. Moonshot automation has its place as an aspirational north star, but without the right foundation it carries a higher risk of failure, delayed value, and lost opportunity. The pragmatic path forward lies in what is deployable and defensible today.

That distinction begins with architecture. Many organizations are still grappling with AI bolted onto fractured data ecosystems, producing fragile results rather than validated ones. Effective AI requires a clinical data intelligence platform where agents operate within a single, coherent clinical workflow. The most reliable agentic systems combine deterministic logic for rule-bound, auditable decisions with generative models for pattern recognition and insight synthesis. That hybrid architecture is what makes AI both intelligent and trustworthy in a regulated environment.

Equally important is governance embedded at the core, not tacked on after deployment. Role-based privileges, complete traceability, and audit-ready records are not compliance overhead. They are what make AI outputs defensible against GCP requirements and regulatory scrutiny. The tools driving real breakthroughs today are grounded in unified data, governed from the start, and built on the combination of deterministic and generative intelligence. That is the line between moonshot and deployable.


By submitting, you agree to the processing of your personal data by eClinical Solutions as described in our Privacy Policy.